Sun Pharma Advanced Research Company Limited

SPARC.NSNSEHealthcare

₹205.00Today1.15% · -₹2.38

Day rangeTrading above day high

₹0.00₹0.00

52W range

54% · ₹108–₹289

Open

₹0.00

Prev close

₹207.38

AskWarren SignalsUpdated 22:27 IST

Momentum Bearish(-1.15% today)Volume 38% Below Avg52W Position Mid-range

Volume

8.1L

38% below avg

Avg vol (20D)

13.1L

20-day baseline

Mkt cap

₹6,660.68Cr

Small Cap

P/E TTM

4.3×

Trade Sun Pharma Advanced Research Company Limited with Artha

Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. It develops Sezaby, a benzyl alcohol and propylene glycol free formulation of phenobarbital sodium injection for the treatment of neonatal seizures; SPARC-121, a novel topical agent for the treatment of Alopecia Areata; and SPARC-122, an anti-MUC1 ADC for treatment of multiple cancer indications. The company is also involved in the development of PDP-716 for treatment of open-angle glaucoma. Sun Pharma Advanced Research Company Limited was incorporated in 2006 and is based in Mumbai, India.

Classification

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Stock ExchangeNSE

Identifiers

Ticker SymbolSPARC.NS

Websitesparc.life

Company Info

HeadquartersNot available

Employees279

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account